CC
BHVN

Centiva Capital’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Centiva Capital’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,485
Closed -$255K – 985
2020
Q2 		$255K Buy
+3,485
New +$185K 0.02% 449

Other funds holding BHVN

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Centiva Capital's BHVN Position: Q3 2020 in Review

Centiva Capital sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2020, closing a stake of 3,485 shares — an estimated $255K sold.

Centiva Capital first reported a position in BHVN in Q2 2020 and held it in 1 quarter. The position peaked at $255K in Q2 2020. 215 funds tracked by Wall St. Rank hold BHVN as of Q3 2020.

  • Centiva Capital reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2020 after selling out during the quarter.
  • Centiva Capital sold 3,485 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2020, an estimated $255K.
  • Centiva Capital first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2020 and held it in 1 quarter.
  • Centiva Capital's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $255K in Q2 2020.
  • 215 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2020.

Based on Centiva Capital's 13F filing for Q3 2020, filed 16 Nov 2020.